Trending: Bristol Myers Gets FDA Priority Review for Reblozyl Expanded Use
14:02 ET -- Bristol Myers Squibb Co. is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The global drugmaker said the U.S.... | May 1, 2023
Bristol Myers Drug Administration Dow Jones Co Merck Co Bristol Myers Squibb Co European Medicines Agency
Source: marketscreener.com